21 May 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Analytica secured a letter of intent from Taiwan's major medical products' distributor, Taiwan Allied Dragon (TAD), which will help roll out Analytica Auto Start Burette initially in Taiwan and later in other Asian markets.
Legal documentation to formalize the relationship is underway. TAD will manage the regulatory approvalfar the Auto Start Burette in the ensuing months and will undergo trials at localhospitals a s part of the market entry proc ess.
Mr Catch Liao, CEO, Taiwan Allied Dragon, said that, "Analytica's AutoStart Burette is in a category of its own and makes a lot of sense for hospitals in Taiwan and the Greater China Region. We are excited to have the opportunity to distribute this innovative technology, helping our hospitals and clinics to be more productive, efficient and safer. We see a very bright future for Analytica and their technologies in Taiwan and the broader region."
Established in 2002, TAD has a strong knowledge of the health market through ownership of hospitals and the manufacture and export of medical technologies. lnvolvement in the health sector, as hospital stakeholders, gives them access to a range of decision makers in the health ministry, national and private hospital networks.